This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethyl group and an amino acid moiety, makes it valuable in the development of drugs targeting neurological disorders, inflammation, and metabolic diseases. It is often employed in the production of chiral compounds due to its ability to act as a building block for enantioselective synthesis. Additionally, it finds use in research settings for studying enzyme inhibition and receptor binding activities, aiding in the discovery of novel therapeutic agents.